|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | E2 enzymes: more than just middle men显示文摘 | Mikaela D Stewart Tobias Rltterhoff Rachel E Klevit Peter S Brzovic | 2016 | Cell Research2016，26，4： | 17 |
| 2 | 血管紧张素受体阻断剂预防男性人群痴呆发生风险研究:前瞻性队列分析(摘要)显示文摘目的探讨血管紧张素受体拮抗剂能否预防阿尔茨海默病和老年痴呆症,或同时减少两种疾病的进展。
设计前瞻性队列分析。
资料来源2002—2006年美国退伍军人数据库。 | Nien-Chen Li Austin Lee Rachel A Whitmer Miia Kivipelto Elizabeth Lawler Lewis E Kazis Benjamin Wolozin 夏曙(译) 于世英(校) | 2010 | 英国医学杂志中文版2010，13，2： | 5 |
| 3 | Current role of palliative interventions in advanced pancreatic cancer显示文摘Pancreatic adenocarcinoma is the third leading cause of cancer death in the United States. Unfortunately, at diagnosis, most patients are not candidates for curative resection. Surgical palliation, a procedure performed with the intention of relieving symptoms or improving quality of life, comes to the forefront of management. This article reviews the palliative management of unresectable pancreatic cancer, including obstructive jaundice, duodenal obstruction and pain control with celiac plexus block. Although surgical bypasses for both biliary and duodenal obstructions usually achieve good technical success, they result in considerable perioperative morbidity and mortality, even when performed laparoscopically. The effectiveness of selfexpanding metal stents for biliary drainage is excellent with low morbidity. Surgical gastrojejunostomy for duodenal obstruction appears to be best for patients with a life expectancy of greater than 2 mo while endoscopic stenting has been shown to be feasible with good symptom relief in those with a shorter life expectancy. Regardless of the palliative procedure performed, all physicians involved must be adequately trained in end of life management to ensure the best possible care for patients. | Chelsey C Ciambella Rachel E Beard Thomas J Miner | 2018 | World Journal of Gastrointestinal Surgery2018，10，7： | 4 |
| 4 | Update on medical and surgical options for patients with acute severe ulcerative colitis: what is new?显示文摘Acute severe ulcerative colitis(UC) is a highly morbid con dition that requires both medical and surgical managementhrough the collaboration of gastroenterologists and colorectal surgeons. First line treatment for patients presenting with acute severe UC consists of intravenous steroids, but those who do not respond require escalation of therapy or emergent colectomy. The mortality of emergent colectomy has declined significantly in recent decades, but due to the morbidity of this procedure, second line agents such as cyclosporine and infliximab have been used as salvage therapy in an attempt to avoid emergent surgery. Unfortunately, protracted medical therapy has led to patients presenting for surgery in a poorer state of health leading to poorer post-operative outcomes. In this era of multiple medical modalities available in the treatment of acute severe UC, physicians must consider the advantages and disadvantages of prolonged medical therapy in an attempt to avoid surgery. Colectomy remains a mainstay in the treatment of severe ulcerative colitis not responsive to corticosteroids and rescue therapy, and timely referral for surgery allows for improved post-operative outcomes with lower risk of sepsis and improved patient survival. Options for reconstructive surgery include three-stage ileal pouchanal anastomosis or a modified two-stage procedure that can be performed either open or laparoscopically. The numerous avenues of medical and surgical therapy have allowed for great advances in the treatment of patients with UC. In this era of options, it is important to maintain a global view, utilize biologic therapy when indicated, and then maintain an appropriate threshold for surgery. The purpose of this review is to summarize the growing number of medical and surgical options available in the treatment of acute, severe UC. | Rachel E Andrew Evangelos Messaris | 2016 | World Journal of Gastrointestinal Surgery2016，8，9： | 4 |
| 5 | Critical analysis of feeding jejunostomy following resection of upper gastrointestinal malignancies显示文摘AIM To assess nutritional recovery,particularly regarding feeding jejunostomy tube(FJT)utilization,following upper gastrointestinal resection for malignancy. METHODS A retrospective review was performed of a prospectively-maintained database of adult patients who underwent esophagectomy or gastrectomy(subtotal or total)for cancer with curative intent,from January 2001 to June 2014. Patient demographics,the approach to esophagectomy,the extent of gastrectomy,FJT placement and utilization at discharge,administration of parenteral nutrition(PN),and complications were evaluated. All patients were followed for at least ninety days or until death.RESULTS The 287 patients underwent upper GI resection,comprised of 182 esophagectomy(n=107 transhiatal,58.7%; n=56 Ivor-Lewis,30.7%)and 105 gastrectomy [n=63 subtotal(SG),60.0%; n=42 total(TG),40.0%]. 181 of 182 esophagectomy patients underwent FJT,compared with 47 of 105 gastrectomy patients(99.5% vs 44.8%,P < 0.0001),of whom most had undergone TG(n=39,92.9% vs n=8 SG,12.9%,P < 0.0001). Median length of stay was similar between esophagectomy and gastrectomy groups(14.7 d vs 17.1 d,P=0.076). Upon discharge,87 esophagectomy patients(48.1%)were taking enteral feeds,with 53(29.3%)fully and 34(18.8%)partially dependent. Meanwhile,20 of 39 TG patients(51.3%)were either fully(n=3,7.7%)or partially(n=17,43.6%)dependent on tube feeds,compared with 5 of 8 SG patients(10.6%),all of whom were partially dependent. Gastrectomy patients were significantly less likely to be fully dependent on tube feeds at discharge compared to esophagectomy patients(6.4% vs 29.3%,P=0.0006). PN was administered despite FJT placement more often following gastrectomy than esophagectomy(n=11,23.4% vs n=7,3.9%,P=0.0001). FJT-specific complications requiring reoperation within 30 d of resection occurred more commonly in the gastrectomy group(n=6),all after TG,compared to 1 esophagectomy patient(12.8% vs 0.6%,P=0.0003). Six of 7 patients(85.7%)who experienced tube-related complications required PN.CONCLUSION Nutritional recovery following esophagectomy and gastrectomy is distinct. Operations are associated with unique complication profiles. Nutritional supplementation alternative to jejunostomy should be considered in particular scenarios. | Andrew M Blakely Saad Ajmal Rachel E Sargent Thomas T Ng Thomas J Miner | 2017 | World Journal of Gastrointestinal Surgery2017，9，2： | 4 |
| 6 | 法证科学中的情境偏差和交叉污染——对侦查、辩诉交易、审判和上诉的腐蚀性影响显示文摘大多数法证科学证据是在这样的条件下形成的,即未保护分析人员免受案件情境信息对他们决策的影响。本文探讨了这些基本未被认识到的威胁是如何给刑事司法系统带来真正的问题的;从对痕迹的收集和解释到在审判和上诉时对证据进行展示和评价。本文解释了分析人员是如何经常接触到与他们的鉴定工作无关的信息(例如关于侦查或主要嫌疑人的信息),并且这些信息没有被记录在他们的报告中,但是这些信息已被证明会影响分析人员对法证科学证据的解释。此外,法证分析人员不仅不必要地接触到这些“与鉴定领域无关”的信息,而且他们受到认知污染的解释和意见往往会被不必要地透露给其他证人-无论是非专业人士还是专业人士。信息的这种来回传播会产生一种“偏差雪球效应”,会导致证据(越来越多地)受到交叉污染,因为在审判和上诉过程中提出的彼此独立的证据要彼此印证。文中指出,律师和法院还没有认识到情境偏差和认知过程是如何扭曲和破坏专家证据的证据价值的。本文建议,法院在采纳和评价归罪性的专家证据时,应该注意到情境偏差和交叉污染的可能性。 | 王进喜(译) 朱海(译) | 2019 | 证据科学2019，27，5： | 3 |
| 7 | A theory of buyer-seller networks 显示文摘 | Rachel E | 2000 | Marketing Science2000，19，4： | 1 |
| 8 | Relationship of energy settings and impedance in different anatomic areas using a radiofrequency device显示文摘 | LACK E B RACHEL J D D'ANDREA L | 2005 | Dermatol Surg2005，31，12： | 1 |
| 9 | A Wavelet Packet Approach to Transient Signal Classification显示文摘 | Learned Rachel E Willsky Alan S | 1995 | Applied and Computational Harmonic Analysis1995，，2： | 1 |
| 10 | Serum antibody levels to three food antigens in atopic and non-atopic subjects 显示文摘 | Hampton S M Morgan J B | 1992 | Int J Food Sci Nutr1992，43，： | 1 |
| 11 | Needs assessment for future US pear rootstock research directions based on the current state of pear production and rootstock research显示文摘 | RACHEL E RICHARD B TODD E | 2012 | Journal of the American Pomological Society2012，66，3： | 1 |
| 12 | On the Issue of Functional Form Choice in Hedonic Price Functions:Further Evidence显示文摘 | Rachel A B Bruce E H | 1997 | Environmental Management1997，21，5： | 1 |
| 13 | In vitro reactivity to implant metals demonstrates a person-dependent association with both T-Cell and B-Cell activation 显示文摘 | Nadim JH Marco C Rachel E | 2009 | Journal of Biomedical Materials Research2009，，： | 1 |
| 14 | A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland显示文摘 | Katrina E G Bert B Rachel S C | 2000 | Breast Cancer Res2000，2，3： | 1 |
| 15 | Attenuating the negative effects of abusive supervi- sion: The role of proactive voice behavior and resource manage- ment ability 显示文摘 | RACHEL E FRIEDER WAYNE A HOCHWARTER PHILIP S DeOrtentiis | 2015 | The Leadership Quarterly2015，26，5： | 1 |
| 16 | A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland 显示文摘 | KATRINA E G BERT B RACHEL S C | 2000 | Breast Cancer Res2000，2，3： | 1 |
| 17 | The Scope and Governance of International R&D Alliances显示文摘 | Sampson Rachelle C | 2004 | Strategic Management Journal2004，25，： | 1 |
| 18 | Personal involvement as a determinant of argument-based persuasion 显示文摘 | Petty R E John T C Rachel G | 1981 | Journal of Personality and Social Psychology1981，41，5： | 1 |
| 19 | Barkow, 'Recharging The Jury:The Criminal Jury's Constitutional Role In An era of Mandatory Sentencing' 显示文摘 | Rachel E | 2003 | University of Pennsylvania Law Review Novemb er2003，，： | 1 |
| 20 | Clinic pathologic, histological,and toxicological findings in 70 cats inadvertently exposed to pet food contaminated with melamine and cyanuric acid显示文摘 | Rachel E C Karyn B Joseph G E | 2008 | Sci Reports2008，233，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员